Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
García Muñiz
J L
JL
Alvarez
A
A
Fernández Llana
B
B
Fernández Raigoso
P
P
Allende
M T
MT
Ruibal
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000782:Aneuploidy; D001365:Axilla; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000145:classification / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry* / Q000145:classification / Q000473:pathology; D002402:Cathepsin D / Q000032:analysis; D003600:Cytosol / Q000737:chemistry*; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D018226:Fibroadenoma / Q000737:chemistry; D005348:Fibrocystic Breast Disease / Q000378:metabolism; D006801:Humans; D008207:Lymphatic Metastasis; D008593:Menopause; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D012307:Risk Factors; D010959:Tissue Plasminogen Activator / Q000032:analysis*
D014408:Biomarkers, Tumor; D002402:Cathepsin D; D066246:ErbB Receptors; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D010959:Tissue Plasminogen Activator